Viewing Study NCT05833867


Ignite Creation Date: 2025-12-25 @ 12:33 AM
Ignite Modification Date: 2026-05-29 @ 7:19 AM
Study NCT ID: NCT05833867
Status: RECRUITING
Last Update Posted: 2024-12-30
First Post: 2023-03-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Adaptive RADiation Therapy with Concurrent Sacituzumab Govitecan (SG) for Muscle Invasive Bladder Cancer
Sponsor: Shilpa Gupta, MD
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: CASE9822
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None UNKNOWN View
None INDUSTRY View